The UroOnc Minute: Cystectomy vs Bladder-Sparing Therapy, with Mary Beth Westerman, MD, FACS

In this episode of The UroOnc Minute, host Adam B. Weiner, MD, is joined by Mary Beth Westerman, MD, FACS, of the University of North Carolina to discuss the landmark CISTO trial—a large pragmatic study examining patient-reported outcomes among individuals with high-risk non–muscle invasive bladder cancer who underwent either bladder-sparing therapy or radical cystectomy.